Background In 2011, Kenya introduced the 10-valent pneumococcal conjugate vaccine together with a catch-up campaign for children aged < 5 years in Kilifi County. In a post-vaccination surveillance study based in Kilifi, there was a substantial decline in invasive pneumococcal disease (IPD). However, given the continued circulation of the vaccine serotypes it is possible that vaccine-serotype disease may re-emerge once the effects of the catch-up campaign wear off. Methods We developed a compartmental, age-structured dynamic model of pneumococcal carriage and invasive disease for three serotype groups: the 10-valent vaccine serotypes and two groups of non-vaccine serotypes based on their susceptibility to mutual competition. The model wa...
BACKGROUND: Ten-valent pneumococcal conjugate vaccine (PCV10), delivered at 6, 10, and 14 weeks of a...
Background In November 2011, Malawi introduced the 13-valent pneumococcal conjugate vaccine (PCV13)...
Summary: Background: Pneumococcal conjugate vaccines (PCV) are highly protective against invasive p...
Background In 2011, Kenya introduced the 10-valent pneumococcal conjugate vaccine together with a ca...
Background: In 2011, Kenya introduced the 10-valent pneumococcal conjugate vaccine together with a c...
BACKGROUND: In 2011, Kenya introduced the 10-valent pneumococcal conjugate vaccine together with a c...
Background The World Health Organisation recommends the use of catch-up campaigns as part of the int...
The 7-valent pneumococcal conjugate vaccine has been introduced in national immunisation programmes ...
The 7-valent pneumococcal conjugate vaccine has been introduced in national immunisation programmes ...
Abstract Background The World Health Organisation recommends the use of catch-up campaigns as part o...
Background Pneumococcal conjugate vaccines (PCV) are highly protective against invasive pneumococcal...
Background Pneumococcal conjugate vaccines (PCV) are highly protective against invasive pneumococcal...
BACKGROUND: The 7-valent pneumococcal conjugate vaccine has been introduced in national immunisation...
Background In November 2011, Malawi introduced the 13-valent pneumococcal conjugate vaccine (PCV13) ...
SummaryBackgroundThe effect of 7-valent pneumococcal conjugate vaccine (PCV) in developed countries ...
BACKGROUND: Ten-valent pneumococcal conjugate vaccine (PCV10), delivered at 6, 10, and 14 weeks of a...
Background In November 2011, Malawi introduced the 13-valent pneumococcal conjugate vaccine (PCV13)...
Summary: Background: Pneumococcal conjugate vaccines (PCV) are highly protective against invasive p...
Background In 2011, Kenya introduced the 10-valent pneumococcal conjugate vaccine together with a ca...
Background: In 2011, Kenya introduced the 10-valent pneumococcal conjugate vaccine together with a c...
BACKGROUND: In 2011, Kenya introduced the 10-valent pneumococcal conjugate vaccine together with a c...
Background The World Health Organisation recommends the use of catch-up campaigns as part of the int...
The 7-valent pneumococcal conjugate vaccine has been introduced in national immunisation programmes ...
The 7-valent pneumococcal conjugate vaccine has been introduced in national immunisation programmes ...
Abstract Background The World Health Organisation recommends the use of catch-up campaigns as part o...
Background Pneumococcal conjugate vaccines (PCV) are highly protective against invasive pneumococcal...
Background Pneumococcal conjugate vaccines (PCV) are highly protective against invasive pneumococcal...
BACKGROUND: The 7-valent pneumococcal conjugate vaccine has been introduced in national immunisation...
Background In November 2011, Malawi introduced the 13-valent pneumococcal conjugate vaccine (PCV13) ...
SummaryBackgroundThe effect of 7-valent pneumococcal conjugate vaccine (PCV) in developed countries ...
BACKGROUND: Ten-valent pneumococcal conjugate vaccine (PCV10), delivered at 6, 10, and 14 weeks of a...
Background In November 2011, Malawi introduced the 13-valent pneumococcal conjugate vaccine (PCV13)...
Summary: Background: Pneumococcal conjugate vaccines (PCV) are highly protective against invasive p...